Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Nov 12, 2025 · 10-Q · 43 days after period end · 0001640334-25-002022
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$3.12M | -$1.13M | -$2.45M | -$2.33M |
| EPS Diluted | -$3.97 | -$2.10 | -$0.83 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end
